Terumobct

Cobio Diagnostics Inc., based in Golden, CO, is a life sciences biotechnology company focused on the development and commercialization of innovative phage-amplified diagnostics aimed at bacterial identification and antibiotic resistance detection. With a commitment to addressing the critical public health challenge of antimicrobial resistance, the company is pioneering rapid diagnostic tools that improve treatment outcomes by delivering timely and accurate results. Its flagship product, the PhAAST-MIC, enables direct-from-specimen bacterial identification and susceptibility testing in under five hours, requiring only basic technical skills and minimal equipment. This scalable and cost-effective method stands out from traditional diagnostics by significantly reducing the time required for results and broadening its applicability to various pathogens, thus addressing the urgent need for more effective monitoring of antibiotic resistance. Generated from the website